2 Layers

Our purpose

To improve life during and beyond sedation

Sedana Medical is a pioneer medtech and pharmaceutical company dedicated to making inhaled sedation a standard therapy in intensive care.

More about us

Bringing inhaled sedation to intensive care

We are proud to introduce inhaled sedation to intensive care, a paradigm shift in the care of critically ill patients.

Through the results obtained in the pivotal study with Sedaconda (isoflurane) and Sedaconda ACD*, we have laid the foundation for inhaled sedation in intensive care.

By this, we have also taken a major step closer to our vision – to make inhaled sedation a standard therapy in intensive care.

*formerly known as AnaConDa

Learn more

Sedana Sedaconda Hand 02 (2)

Clinical Research

Our vision is for inhaled sedation to be a global standard therapy for patients in intensive care.

To achieve this, we will through clinical research pave the way for a paradigm shift in sedation in the intensive care.

Our research aims at a greater understanding of and increased knowledge about inhaled sedation, leading to medical advances for the benefit of patients in intensive care.

We also believe in working in partnerships – through various initiatives and research projects – that can lead to continued development and meaningful improvement for both patients and the healthcare system.

Learn More

Press Releases

Sedana Medical AB Interim report January-June 2022

Regulatory

Committed to change the standard of care, with commercial progress and a strong balance sheet.

Invitation to presentation of Sedana Medical’s interim report for the second quarter 2022

Non-regulatory

Sedana Medical AB (publ) plans to present its interim report for the second quarter 2022 in an audio…

View All Press Releases

Our products

Explore our broad portfolio of products for the administration of inhaled anaesthetics.

Learn More

View All Products